![]() | ![]() |
Formats:
|
||||||||||
Copyright © 2008, Baylor University Medical Center Complementary utility of multislice computed tomographic coronary angiography for detection of high-grade lesions in patients with negative stress myocardial perfusion imaging From the Division of Cardiology, Department of Internal Medicine (Gupta, Anwar, Schussler), and the Division of Nuclear Medicine, Department of Radiology (Brophey), Baylor University Medical Center and Baylor Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, Texas. Corresponding author.Corresponding author: Jeffrey M. Schussler, MD, FACC, FSCAI, 621 North Hall Street, Suite 500, Dallas, Texas 75226 (e-mail: Jeffrey.Schussler/at/heartplace.com). Abstract Myocardial perfusion imaging (MPI) is a highly sensitive and specific test for noninvasive detection of coronary artery disease. Therefore, in patients with negative MPI results, further noninvasive testing is usually not pursued. We report a series of patients with negative MPI results in whom 64-slice computed tomographic coronary angiography accurately predicted flow-limiting coronary lesions requiring subsequent revascularization. Myocardial perfusion imaging (MPI) is a highly sensitive and specific test for the diagnosis of coronary artery disease (CAD), with reported sensitivity of 87% to 89% and specificity of 73% to 75% (1). In patients with symptoms suggestive of angina, MPI is often done as the primary diagnostic test. Although a negative MPI result usually portends a very good prognosis (2), it does not rule out CAD, especially in patients who have a moderate pretest probability of CAD. As a result, in patients with persistent symptoms of chest pain, a moderate risk of CAD, and a negative MPI result, further testing may still be performed to convincingly rule out obstructive coronary stenoses. Computed tomographic coronary angiography (CTCA) is a rapidly evolving noninvasive modality for doing coronary angiography that has been shown to have acceptable sensitivity and specificity (3). However, its utility in predicting CAD in patients with normal MPI scans is unknown. We report a series of patients in whom 64-slice CTCA was performed after a negative or low-probability MPI result due to continued clinical suspicion. In each of these cases, significant flow-limiting disease was suggested by the CTCA and then subsequently confirmed by invasive coronary angiography. METHODS A series of “moderate”-risk patients underwent a dualisotope myocardial perfusion study in the clinical setting of chest pain. A weight-adjusted dose of thallium (on average 3 mCi) was injected in the resting condition. Subsequently, during adenosine infusion or following peak treadmill exercise, the patients were injected with a second dose of approximately 24 mCi of 99mTc-MIBI, and a gated acquisition was performed. Corresponding tomographic slices in the stress and resting phases were directly compared using a visual qualitative inspection to assess for perfusion. Wall motion, thickening, and an estimated left ventricular ejection fraction were generated from a separate review of the gated data. All the perfusion images were read by experienced readers. Due to continued clinical suspicion and ongoing symptoms of angina, these patients underwent 64-slice CTCA (LightSpeed VCT, GE Healthcare) to further define coronary anatomy. Patients' heart rates were lowered using pre-CT beta-blockade where applicable, with additional intravenous beta-blockers given at the time of the scan. Sublingual nitroglycerine was given prior to the scan as a part of the routine protocol. CTCAs were interpreted by a reader with level 3-equivalent experience in CTCA (4). In each of these cases, the results from the CT suggested “high-grade” lesions in one or more arteries. Invasive angiography was performed, and the results of the CTCA were then compared with those obtained from conventional angiography. RESULTS CTCA demonstrated single-vessel CAD involving the left anterior descending artery in two patients. Two-vessel disease involving the left anterior descending and right coronary arteries was detected on CTCA in two patients. Three-vessel CAD was found in the remaining three patients (Table). In all patients, there was excellent anatomic correlation with invasive angiography (Figures (Figures11
Based on angiography results, patients with either single or two-vessel disease underwent percutaneous coronary intervention with drug-eluting stent implantation. All three patients with triple-vessel disease underwent coronary artery bypass surgery. DISCUSSION A “normal” MPI defines a population with a low probability of future cardiac events (2). However, there are well-described false-negative MPI scans (5). This may be due to “balanced disease” or lack of a flow-limiting lesion under testing conditions. As a result, in some patients with a negative MPI scan, further testing to rule out CAD may be warranted. This is especially true in the setting of continued symptoms. Multislice CTCA has recently emerged as a noninvasive modality for detection of CAD, with high sensitivity and specificity reported in the literature (3). Like invasive angiography, multislice CTCA can accurately reveal distribution of atherosclerotic plaques in the coronary bed and the degree of flow limitation. As a result, multislice CTCA can potentially help identify patients who have near-normal MPI scans due to balanced multivessel disease. In this case series, CTCA was able to accurately diagnose single-vessel and multivessel disease despite normal MPI scans in a population with a moderate pretest probability of CAD. Nuclear perfusion scan is often the first test performed in the evaluation of a cardiac patient with moderate pretest probability of CAD. In some of these patients with normal or “near-normal” nuclear scans, further testing is warranted due to ongoing unexplained symptoms or continued concern for the patient's well-being. In these circumstances, CTCA may be a complementary noninvasive testing modality for the further evaluation of patients with negative MPI scans. References 1. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, O'Gara PT, Carabello BA, Russell RO, Jr, Cerqueira MD, St John Sutton MG, DeMaria AN, Udelson JE, Kennedy JW, Verani MS, Williams KA, Antman EM, Smith SC, Jr, Alpert JS, Gregoratos G, Anderson JL, Hi-ratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO., American College of Cardiology. American Heart Association Task Force on Practice Guidelines. American Society for Nuclear Cardiology ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—executive summary. Circulation. 2003;108(11):1404–1418. [PubMed] 2. Hachamovitch R, Hayes S, Friedman JD, Cohen I, Shaw LJ, Germano G, Berman DS. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol. 2003;41(8):1329–1340. [PubMed] 3. Ropers D, Baum U, Pohle K, Anders K, Ulzheimer S, Ohnesorge B, Schlundt C, Bautz W, Daniel WG, Achenbach S. Detection of coronary artery stenoses with thin-slice multi-detector row spiral computed tomography and multiplanar reconstruction. Circulation. 2003;107(5):664–666. [PubMed] 4. Budoff MJ, Cohen MC, Garcia MJ, Hodgson JM, Hundley WG, Lima JA, Manning WJ, Pohost GM, Raggi PM, Rodgers GP, Rumberger JA, Taylor AJ, Creager MA, Hirshfeld JW, Jr, Lorell BH, Merli G, Rodgers GP, Tracy CM, Weitz HH., American College of Cardiology Foundation. American Heart Association. American College of Physicians Task Force on Clinical Competence and Training. American Society of Echocardiography. American Society of Nuclear Cardiology. Society of Atherosclerosis Imaging. Society for Cardiovascular Angiography & Interventions. ACCF/AHA clinical competence statement on cardiac imaging with computed tomography and magnetic resonance. J Am Coll Cardiol. 2005;46(2):383–402. [PubMed] 5. Berman DS, Shaw LJ, Hachamovitch R, Friedman JD, Polk DM, Hayes SW, Thomson LE, Germano G, Wong ND, Kang X, Rozanski A. Comparative use of radionuclide stress testing, coronary artery calcium scanning, and noninvasive coronary angiography for diagnostic and prognostic cardiac assessment. Semin Nucl Med. 2007;37(1):2–16. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||
Circulation. 2003 Sep 16; 108(11):1404-18.
[Circulation. 2003]J Am Coll Cardiol. 2003 Apr 16; 41(8):1329-40.
[J Am Coll Cardiol. 2003]Circulation. 2003 Feb 11; 107(5):664-6.
[Circulation. 2003]J Am Coll Cardiol. 2005 Jul 19; 46(2):383-402.
[J Am Coll Cardiol. 2005]J Am Coll Cardiol. 2003 Apr 16; 41(8):1329-40.
[J Am Coll Cardiol. 2003]Semin Nucl Med. 2007 Jan; 37(1):2-16.
[Semin Nucl Med. 2007]Circulation. 2003 Feb 11; 107(5):664-6.
[Circulation. 2003]